Department of Cancer Biology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois 60153, United States ...

Researchers from Wuyi University presented the discovery and preclinical characterization of kinesin spindle protein (KSP) degraders developed using proteolysis-targeting chimera (PROTAC) technology.

Merck Sharp & Dohme LLC patents report the development of proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase (Von Hippel-Lindau disease tumor suppressor [VHL] ligands) ...

After hours: February 13 at 6:07:10 PM EST Loading Chart for DLO ...

Research analysts at Leerink Partnrs upped their Q1 2025 earnings per share estimates for Arvinas in a research report issued ...

After hours: February 14 at 7:46:16 PM EST Loading Chart for FLEX ...

Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences, Max-von-Laue ...

ITI Ltd., incorporated in the year 1950, is a Mid Cap company (having a market cap of Rs 25,996.80 Crore) operating in Telecommunications sector. ITI Ltd. key Products/Revenue Segments include Sale of ...

NEW HAVEN, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company ...

The proteasome is a large protein complex in the cytoplasm of eukaryotic and archaeal cells responsible for proteolysis of proteins that have one or more poly-ubiquitin post-translational ...

Arvinas (NASDAQ:ARVN – Get Free Report)‘s stock had its “outperform” rating reiterated by BMO Capital Markets in a research report issued to clients and investors on Wednesday,Benzinga reports. They ...